Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, University of London, UK.
Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
Int J Infect Dis. 2023 Apr;129:125-134. doi: 10.1016/j.ijid.2023.01.029. Epub 2023 Feb 2.
To document the changes in HIV incidence over thirty years in Kalungu district, Uganda.
Since 1989, residents aged ≥15 years old have been tested for HIV, and data were collected on HIV risk factors annually and later, biennially in the Kyamulibwa open cohort. In the 2019-2021 survey, people living with HIV self-reported on knowledge of their HIV status, antiretroviral therapy (ART) use, and their most recent viral load data were obtained from health facilities. The HIV seroconversion dates were randomly imputed between the last negative and first positive test dates using a uniform distribution.
Among 20,959 residents who were HIV-negative, 669 seroconverted within 176,659 person-years. Data showed a downward trend in age-adjusted HIV incidence over 30 years (P <0.001) even though HIV prevalence steadily increased with ART availability from 2004. Comparing 1990-1992 and 1996-1998, HIV incidence declined by 43% (0.79 to 0.45/100 person-years, P = 0.002). Between 1999 and 2011, the incidence remained stable at 0.49/100 person-years (95% confidence interval: 0.41-0.58) in men but slowly increased in women (average age-adjusted hazard ratio = 1.13 per 3 years, 95% confidence interval: 1.03-1.24; trend P-value = 0.02). After 2011, however, the incidence trends reversed and continued to decline in men and women and in all age groups.
Facilitating HIV testing and timely ART initiation, and supporting ART adherence must be emphasized alongside sustainable prevention measures.
记录乌干达卡伦古区 30 多年来艾滋病毒发病率的变化。
自 1989 年以来,年龄≥15 岁的居民接受了艾滋病毒检测,每年收集艾滋病毒风险因素数据,随后在 Kyamulibwa 开放队列中每两年收集一次。在 2019-2021 年的调查中,艾滋病毒感染者自行报告了对艾滋病毒状况、抗逆转录病毒疗法(ART)使用情况的了解,其最近的病毒载量数据从卫生机构获得。艾滋病毒血清转换日期使用均匀分布在最后一次阴性和第一次阳性检测日期之间随机推断。
在 20959 名艾滋病毒阴性居民中,669 人在 176659 人年中发生血清转换。数据显示,尽管随着 2004 年抗逆转录病毒药物的普及,艾滋病毒流行率稳步上升,但 30 年来年龄调整后的艾滋病毒发病率呈下降趋势(P<0.001)。将 1990-1992 年与 1996-1998 年进行比较,艾滋病毒发病率下降了 43%(0.79 至 0.45/100 人年,P=0.002)。在 1999 年至 2011 年期间,男性的发病率保持在 0.49/100 人年(95%置信区间:0.41-0.58),但女性的发病率缓慢上升(平均年龄调整后的危险比为每 3 年增加 1.13,95%置信区间:1.03-1.24;趋势 P 值=0.02)。然而,2011 年之后,发病率趋势发生逆转,男性和女性以及所有年龄组的发病率继续下降。
必须强调促进艾滋病毒检测和及时启动抗逆转录病毒治疗,并支持抗逆转录病毒治疗的依从性,同时还要持续采取预防措施。